Patient profile | Tissue ID | Overall survival (days) | Onset age | Sex | ATAC-seq | RNA-seq |
---|---|---|---|---|---|---|
Short-survival (chemoresistant; CR) (< 0.5 years) | Short-Survival-1 | 145 | 58 | M | v | v |
Short-Survival-2 | 147 | 72 | F | v | v | |
Short-Survival-3 | 173 | 58 | M | - | v | |
Short-Survival-4 | 183 | 68 | F | v | v | |
Short-Survival-5 | 112 | 41 | M | v | – | |
Long-survival (chemosensitive; CS) (> 2 years) | Long-survival-1 | 1500 | 58 | M | v | v |
Long-survival-2 | 2633 | 57 | M | - | v | |
Long-survival-3 | 1037 | 61 | M | v | v | |
Long-survival-4 | 1461 | 54 | M | v | v | |
Long-survival-5 | 1597 | 54 | F | v | – | |
Normal | Normal-1 | Â | 63 | F | v | v |
Normal-2 | Â | 54 | M | v | v | |
Normal-3 |  | 53 | M | v | – | |
Normal-4 |  | 65 | M | v | – |